Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

1.79B

Market cap1.79B

Price-Earnings ratio

-7.06

Price-Earnings ratio-7.06

Dividend yield

—

Dividend yield—

Average volume

7.14M

Average volume7.14M

High today

$18.35

High today$18.35

Low today

$17.63

Low today$17.63

Open price

$17.70

Open price$17.70

Volume

4.64M

Volume4.64M

52 Week high

$155.95

52 Week high$155.95

52 Week low

$16.88

52 Week low$16.88

SRPT News

Simply Wall St 7d

Sarepta Therapeutics (NasdaqGS:SRPT) Faces Shipment Suspension Amid Safety Update

recently provided updates that may have influenced its stock performance. The announcement of a safety update for ELEVIDYS, concerning severe side effects and a...

Analyst ratings

54%

of 28 ratings

Buy

53.6%

Hold

42.9%

Sell

3.6%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.